STOCK TITAN

Cannae Holdings Form 4 Filings

CNNE NYSE

Every Form 4 that Cannae Holdings (CNNE) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CNNE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CNNE filings page.

Rhea-AI Summary

Cannae Holdings, Inc. CEO Ryan R. Caswell reported equity compensation-related transactions involving restricted stock units and common stock. On 2026-08-13, 33,333 restricted stock units vested and were disposed to the issuer in exchange for 33,333 shares of common stock, as described in a footnote. Following this vesting, Caswell held 366,667 restricted stock units. On the same date, 13,116 shares of common stock were delivered or withheld at $15.56 per share for payment of exercise price or tax liability.

Rhea-AI Summary

Cannae Holdings director Tyler Woodrow reported an equity grant of 1,086 shares of Common Stock. The shares were acquired at a reported price of $14.40 per share under the company’s Director Retainer Election Program. Following this compensation-related award, Woodrow directly holds 16,342 shares of Cannae Holdings common stock.

Rhea-AI Summary

Schaible Cherie L reported acquisition or exercise transactions in this Form 4 filing.

Cannae Holdings director Cherie L. Schaible received 2,171 shares of Common Stock on a grant basis valued at $14.40 per share. These shares were obtained under the company’s Director Retainer Election Program and increased her directly held stake to 10,861 shares following the transaction.

Rhea-AI Summary

Harris Hugh R reported acquisition or exercise transactions in this Form 4 filing.

Cannae Holdings director Hugh R. Harris received a grant of 1,129 shares of common stock at $14.40 per share under the company’s Director Retainer Election Program. This compensation-related award is not an open-market transaction and increases his direct holdings to 70,446 shares.

Rhea-AI Summary

Ammerman Douglas K reported acquisition or exercise transactions in this Form 4 filing.

Cannae Holdings director Douglas K. Ammerman received 3,039 shares of Common Stock as compensation under the company’s Director Retainer Election Program. The shares were valued at $14.40 per share on the grant date. After this award, he directly owns 72,025 Cannae Holdings shares.

Rhea-AI Summary

Cannae Holdings, Inc. executive vice president and chief legal officer Peter T. Sadowski reported an insider transaction involving his IRA. On April 8, 2026, a non-derivative open-market sale of 157 shares of Cannae common stock was executed at $12.25 per share, leaving the IRA with no remaining shares.

In addition to this IRA activity, Sadowski reported direct holdings of 53,640 shares through the Sadowski Living Trust and 101,471 shares of Cannae common stock held directly after the reported date. The filing does not show any derivative securities, so his reported ownership consists solely of common stock held across these accounts.

Rhea-AI Summary

Cannae Holdings, Inc. director Tyler Woodrow received an equity award of common stock as part of his board compensation. On 2026-03-31, he acquired 1,375 shares of Common Stock at $11.37 per share under the company’s Director Retainer Election Program. Following this grant, he directly holds 15,256 common shares, indicating a routine, compensation-related acquisition rather than an open-market purchase.

Rhea-AI Summary

Schaible Cherie L reported acquisition or exercise transactions in this Form 4 filing.

Cannae Holdings, Inc. director Cherie L. Schaible received a grant of 2,437 shares of Common Stock, valued at $11.37 per share. This was a compensation-related award under the Director Retainer Election Program and increased her direct holdings to 8,690 shares.

Rhea-AI Summary

Cannae Holdings, Inc. director Hugh R. Harris acquired 1,430 shares of common stock on March 31, 2026 through a grant under the company’s Director Retainer Election Program. The shares were valued at $11.37 per share, bringing his direct holdings to 69,317 shares.

This was recorded as a non-derivative grant or award, reflecting equity-based director compensation rather than an open-market purchase or sale.

Rhea-AI Summary

Ammerman Douglas K reported acquisition or exercise transactions in this Form 4 filing.

Cannae Holdings, Inc. director Douglas K. Ammerman received an award of 3,848 shares of common stock on March 31, 2026. The shares were valued at $11.37 per share and were obtained under the company’s Director Retainer Election Program. Following this grant, Ammerman directly holds 68,986 shares of Cannae common stock. This is a compensation-related equity award rather than an open-market purchase or sale.

Rhea-AI Summary

Cannae Holdings, Inc. executive Michael L. Gravelle reported a routine tax-related share disposition. On this Form 4, 1,681 shares of common stock were withheld at $11.08 per share to satisfy tax obligations. After this transaction, he directly holds 182,912 common shares.

Rhea-AI Summary

Cannae Holdings, Inc. executive vice president and chief legal officer Peter T. Sadowski reported a tax-related share disposition. On March 13, 2026, 2,435 shares of common stock were withheld at $11.51 per share to cover tax obligations, rather than sold in the open market. After this transaction, he directly held 101,471 shares of Cannae common stock. Separate holding entries show 157 shares in a Peter Sadowski IRA and 53,640 shares in the Sadowski Living Trust.

Rhea-AI Summary

Cannae Holdings, Inc. Chief Financial Officer Coy Bryan D. reported a routine tax-related share disposition. On March 13, 2026, 4,245 shares of common stock were delivered at $11.51 per share to cover tax obligations. After this transaction, he directly holds 83,987 shares of Cannae common stock.

Rhea-AI Summary

Cannae Holdings CEO Ryan R. Caswell reported a compensation-related share adjustment. On March 13, 2026, 19,597 shares of Common Stock were disposed of at $11.51 per share to cover tax obligations, a non-market transaction. After this tax-withholding disposition, he directly holds 289,681 Common shares and 400,000 Restricted Stock Units, indicating he retains a substantial equity stake.

Rhea-AI Summary

SADOWSKI PETER T reported acquisition or exercise transactions in this Form 4 filing.

Cannae Holdings EVP and Chief Legal Officer Peter T. Sadowski received a grant of 20,765 shares of common stock on March 9, 2026. The award was granted at no cash cost per share as equity compensation, increasing his directly held shares to 103,906.

The restricted stock vests in three equal annual installments beginning on March 9, 2027, tying the value of this award to Sadowski’s continued service and the company’s long-term performance.

Rhea-AI Summary

Cannae Holdings, Inc. reported that executive vice president and general counsel Michael L. Gravelle received a grant of 20,765 shares of common stock as equity compensation. The grant consists of restricted stock that will vest in three equal annual installments beginning on March 9, 2027. After this award, Gravelle directly holds 184,593 shares of Cannae common stock. This is a compensation-related acquisition rather than an open-market purchase.

Rhea-AI Summary

FOLEY WILLIAM P II reported acquisition or exercise transactions in this Form 4 filing.

Cannae Holdings, Inc. director and ten percent owner William P. Foley II received a grant of 150,000 Restricted Stock Units on March 9, 2026. Each RSU represents the right to receive one share of common stock and carries pass-through voting rights and rights to accrued dividends, if declared, during the vesting period.

The RSUs vest in three equal annual installments beginning on March 9, 2027, so the award is spread over three years. Following this grant, Foley reports 150,000 RSUs directly and direct ownership of 1,008,235 shares of common stock, along with additional indirect common stock holdings through Folco Development Corp., Foley Family Enterprises LLC, and Foley Family Charitable Foundation.

Rhea-AI Summary

Caswell Ryan R. reported acquisition or exercise transactions in this Form 4 filing.

Cannae Holdings CEO Ryan R. Caswell reported an equity compensation grant of 150,000 Restricted Stock Units (RSUs). Each RSU represents the right to receive one share of Cannae common stock and includes pass-through voting rights and rights to accrued dividends, if declared, payable upon vesting.

The RSUs vest in three equal annual installments beginning on March 9, 2027, so the award is spread over several years. Following this grant, Caswell directly holds 400,000 RSUs and 309,278 shares of Cannae common stock, reflecting both his unvested awards and current share ownership.

Rhea-AI Summary

Cannae Holdings, Inc. executive Peter T. Sadowski, EVP and Chief Legal Officer, reported two tax-related share dispositions under a Form 4. On February 28, 2026, 3,432 shares of common stock at $12.20 per share were used to satisfy tax obligations, leaving him with 83,141 directly owned shares.

On February 26, 2026, an earlier tax-withholding disposition covered 886 shares at $12.57 per share. Both transactions are coded “F,” indicating payment of exercise price or tax liability by delivering securities, rather than ordinary open-market buying or selling.

Rhea-AI Summary

Cannae Holdings Executive Vice President Michael L. Gravelle reported a tax-related share disposition. On February 26, 2026, 1,266 shares of Cannae Holdings common stock were disposed of at an indicated price of $12.57 per share to satisfy tax withholding obligations.

After this tax-withholding disposition, Gravelle’s directly owned stake in Cannae Holdings stood at 163,828 common shares, showing he continues to hold a substantial number of shares following the transaction.

Rhea-AI Summary

Cannae Holdings Chief Financial Officer Coy Bryan D. reported two tax-related share dispositions of Cannae common stock. On February 26, he surrendered 760 shares at $12.57 per share, and on February 28 he surrendered 4,590 shares at $12.20 per share to cover tax obligations. After these non-open-market transactions, he directly owned 88,232 common shares.

Rhea-AI Summary

Cannae Holdings, Inc. CEO Ryan R. Caswell reported a mix of equity award vesting, share grants, and related dispositions. On February 26, 2026 and February 28, 2026, previously granted restricted stock units vested, and he received 30,325 shares of common stock on each vesting date, as described in the footnotes.

In connection with these events, he reported dispositions of restricted stock units and common stock back to the issuer and for tax withholding, including multiple Form 4 codes D (disposition to issuer) and F (tax-withholding disposition). He also reported stock awards of 30,325 shares of common stock on each date. Following these transactions, his directly held common stock balance was reported at 309,278 shares on February 28, 2026.

Rhea-AI Summary

Cannae Holdings director Cherie L. Schaible reported receiving additional shares of the company’s common stock as part of her board compensation. On December 31, 2025, she acquired 277 shares of Cannae Holdings, Inc. common stock at $15.73 per share under the company’s Director Retainer Election Program, which allows directors to take retainers in equity. After this transaction, she beneficially owned 6,253 common shares, held directly in her name. This filing reflects routine equity-based compensation rather than an open-market trade.

Rhea-AI Summary

Cannae Holdings, Inc. director Cherie L. Schaible reported a stock grant. On December 15, 2025, she was awarded 4,616 shares of common stock at a stated price of $0, reflecting a grant of restricted stock rather than an open-market purchase.

After this award, she beneficially owns 5,976 shares of Cannae common stock in direct ownership. The restricted stock is scheduled to vest in three equal annual installments beginning on December 15, 2026, meaning one-third of the grant becomes unrestricted each year over a three-year period.

Rhea-AI Summary

Cannae Holdings, Inc. reported an insider equity transaction by one of its directors. On 12/31/2025, the director acquired 994 shares of Cannae Holdings common stock at a price of $15.73 per share. The filing states that these shares were obtained under the company’s Director Retainer Election Program, which allows directors to receive retainers in stock rather than cash.

Following this transaction, the director beneficially owns 13,881 shares of Cannae Holdings common stock in direct ownership. The report is filed as a Form 4 by a single reporting person in the capacity of a director, indicating routine compensation-related share issuance rather than a market purchase or sale.

Rhea-AI Summary

Cannae Holdings, Inc. director reported an acquisition of company stock. On 12/31/2025, the reporting person acquired 1,034 shares of Cannae Holdings common stock at a price of $15.73 per share, coded as an acquisition transaction. After this transaction, the director beneficially owned 67,887 shares, held directly.

The filing notes that the shares were obtained under the company’s Director Retainer Election Program, indicating they were received as part of director compensation rather than an open-market purchase.

Rhea-AI Summary

Cannae Holdings, Inc. director reported acquiring additional company stock through a routine board compensation program. On 12/31/2025, the director obtained 2,782 shares of common stock at a price of $15.73 per share under the Director Retainer Election Program. Following this transaction, the director beneficially owns 65,138 shares of Cannae Holdings common stock in direct form. This filing documents an equity-based component of director compensation rather than an open-market purchase or sale.

Rhea-AI Summary

Cannae Holdings director reports restricted stock grant

A director of Cannae Holdings, Inc. reported receiving 4,616 shares of common stock as a restricted stock grant on December 15, 2025. The award was recorded at a price of $0 per share, reflecting an equity compensation grant rather than an open-market purchase. These restricted shares are scheduled to vest in three equal annual installments beginning December 15, 2026.

After this grant, the director beneficially owns 5,122.9754 shares of Cannae Holdings common stock directly, plus 900 shares held indirectly through the K6 Investments Defined Benefit Plan.

Rhea-AI Summary

Cannae Holdings (CNNE) reported an insider equity award on a Form 4. A director acquired 7,818 shares of common stock on 11/12/2025 with a transaction code “A” at a stated price of $0, reflecting a grant of restricted stock. The award vests in three equal annual installments beginning November 12, 2026.

Rhea-AI Summary

Cannae Holdings (CNNE) reported an insider equity grant. A director received 7,818 shares of common stock on 11/12/2025 coded “A” (award) at $0. Following the grant, the director beneficially owned 12,887 shares, held directly.

The award is restricted stock that vests in three equal annual installments beginning November 12, 2026, as disclosed in the footnote.

Rhea-AI Summary

Cannae Holdings, Inc. (CNNE) reported an insider equity award. A director received a grant of 7,818 shares of common stock on November 12, 2025 at $0 per share as a restricted stock award. According to the footnote, the award vests in three equal annual installments beginning November 12, 2026. Following this transaction, the reporting person beneficially owns 34,279 shares with direct ownership.

Rhea-AI Summary

Cannae Holdings (CNNE) reported an insider equity award on Form 4. A company director received 7,818 shares of common stock on 11/12/2025 at a reported price of $0, reflecting a standard restricted stock grant.

The award vests in three equal annual installments beginning November 12, 2026. Following this transaction, the director beneficially owns 11,785 shares, held directly. This filing indicates routine director compensation via restricted stock with a multi‑year vesting schedule.

Rhea-AI Summary

Cannae Holdings (CNNE) reported a director equity grant. On 11/12/2025, a director acquired 7,818 shares of common stock at $0, reflecting a restricted stock award. Following the transaction, beneficial ownership stood at 32,753 shares, held directly.

The award vests in three equal annual installments beginning 11/12/2026, aligning compensation with multi‑year service. This filing documents insider equity compensation rather than an open‑market purchase.

Rhea-AI Summary

Cannae Holdings (CNNE) reported an insider equity award. A director acquired 7,818 shares of common stock at $0 on 11/12/2025, reflecting a restricted stock grant.

Following the transaction, the reporting person beneficially owns 143,942 shares held directly. The grant vests in three equal annual installments beginning November 12, 2026.

Rhea-AI Summary

Cannae Holdings (CNNE) reported an insider equity award. A director acquired 7,818 shares of common stock on 11/12/2025 as an “A” code transaction, reflecting a grant priced at $0. Following this award, the reporting person beneficially owned 207,437 shares directly.

The grant is described as restricted stock that will vest in three equal annual installments beginning November 12, 2026. The filing also lists 0 shares held indirectly via the Frank and Marisa Martire 2012 Florida Trust after the reported transaction.

Rhea-AI Summary

Cannae Holdings (CNNE) reported an insider equity award. A director acquired 7,818 shares of common stock on 11/12/2025 at a reported price of $0, reflecting a restricted stock grant. Following the transaction, the director’s beneficial ownership stands at 28,818 shares.

The award vests in three equal annual installments beginning November 12, 2026, aligning compensation with longer-term service. This filing documents the grant and updated holdings; it does not indicate any open-market purchase or sale.

Rhea-AI Summary

Cannae Holdings (CNNE) reported an insider equity award. A director received a grant of 7,818 shares of restricted stock on November 12, 2025 at $0. The award vests in three equal annual installments beginning November 12, 2026.

Following the grant, the director beneficially owns 34,733 shares directly. Indirect holdings include 1,942 shares through Holland III Family LP and 8,058 shares through the Malcolm Holland IRA.

Rhea-AI Summary

Cannae Holdings, Inc. (CNNE) reported an insider equity grant. A director acquired 7,818 shares of common stock on 11/12/2025 at $0, coded as an acquisition (A).

The filing notes this was a grant of restricted stock that vests in three equal annual installments beginning November 12, 2026. Following this transaction, the director beneficially owns 66,853 shares, held directly.

Rhea-AI Summary

Cannae Holdings (CNNE): Form 4 insider equity grant. A director received 15,635 shares of common stock as a restricted stock award on 11/12/2025 at $0. The award vests in three equal annual installments beginning November 12, 2026.

Following the transaction, beneficial ownership is reported as 1,008,235 shares direct and indirect holdings of 748,299 via Folco Development Corp., 236,011 via Foley Family Charitable Foundation, and 2,849,803 via Foley Family Enterprises LLC.

Rhea-AI Summary

Cannae Holdings (CNNE) reported a director equity grant on a Form 4. On 11/12/2025, the reporting person acquired 23,453 shares of common stock at $0, identified as a grant of restricted stock.

Following the transaction, the director beneficially owns 62,356 shares, held directly. The grant vests in three equal annual installments beginning November 12, 2026.

Rhea-AI Summary

Tyler Woodrow, a director of Cannae Holdings, Inc. (CNNE), reported acquiring 854 shares of common stock on 09/30/2025 at a price of $18.31 per share under the company Director Retainer Election Program. Following this transaction, Mr. Woodrow beneficially owns 5,069 shares in a direct capacity. The Form 4 is filed by one reporting person and was signed on behalf of the reporting person by an attorney-in-fact.

Rhea-AI Summary

Erika Meinhardt, a director of Cannae Holdings, Inc. (CNNE), acquired 922 shares of the company's common stock on 09/30/2025 at a price of $18.31 per share under the Director Retainer Election Program. After this transaction she beneficially owns 136,124 shares in a direct capacity. The Form 4 was signed by an attorney-in-fact on 10/01/2025. This filing records a routine director compensation election resulting in an incremental increase in the director's direct shareholdings.

Rhea-AI Summary

Hugh R. Harris, a director of Cannae Holdings, Inc. (CNNE), acquired 888 shares of the company's common stock on 09/30/2025 at a price of $18.31 per share under the Director Retainer Election Program. Following this transaction, Mr. Harris beneficially owned 59,035 shares in a direct capacity. The Form 4 filing was executed on 10/01/2025 by Carol Nairn as attorney-in-fact. The report reflects a routine issuance tied to director compensation rather than an open-market purchase or sale.

Rhea-AI Summary

Douglas K. Ammerman, a director of Cannae Holdings, Inc. (CNNE), reported acquiring 3,140 shares of the company's common stock on 09/30/2025 at a reported price of $18.31 per share under the Director Retainer Election Program. After the transaction, Mr. Ammerman beneficially owned 38,903 shares. The Form 4 was signed by an attorney-in-fact on 10/01/2025. The filing discloses a non-derivative purchase by an insider as part of a director compensation election; no options, dispositions, or other derivative transactions are reported.

Rhea-AI Summary

Amended Form 4 for Cannae Holdings (CNNE) — This filing corrects a prior Form 4 to report that director Malcolm C. Holland III received a 2024 annual restricted stock award dated November 14, 2024 for 6,119 restricted shares at a reported price of $0. The shares are scheduled to vest in three equal annual installments beginning November 14, 2025. After the reported grant, the filing shows 26,915 shares beneficially owned directly, plus 1,942 shares held indirectly through Holland III Family LP and 8,058 shares held indirectly in Malcolm Holland IRA. The amendment states the correction was due to a technical error in the registrant's electronic filing system.